182 related articles for article (PubMed ID: 33442865)
1. Influence of relevant cystic fibrosis bacteria on Scedosporium apiospermum and Scedosporium boydii growth and viability.
Marques AJ; Rollin-Pinheiro R; Xisto MIDDS; Dos Santos ALS; Barreto-Bergter E; Liporagi-Lopes LC
Braz J Microbiol; 2021 Mar; 52(1):185-193. PubMed ID: 33442865
[TBL] [Abstract][Full Text] [Related]
2. Identification of Scedosporium boydii catalase A1 gene, a reactive oxygen species detoxification factor highly expressed in response to oxidative stress and phagocytic cells.
Mina S; Staerck C; d'Almeida SM; Marot A; Delneste Y; Calenda A; Tabiasco J; Bouchara JP; Fleury MJJ
Fungal Biol; 2015 Dec; 119(12):1322-1333. PubMed ID: 26615753
[TBL] [Abstract][Full Text] [Related]
3. Peptidorhamnomannans From
de Oliveira EB; Xisto MIDDS; Rollin-Pinheiro R; Rochetti VP; Barreto-Bergter E
Front Cell Infect Microbiol; 2020; 10():598823. PubMed ID: 33251161
[No Abstract] [Full Text] [Related]
4. Semi-automated repetitive sequence-based PCR amplification for species of the Scedosporium apiospermum complex.
Matray O; Mouhajir A; Giraud S; Godon C; Gargala G; Labbé F; Rougeron A; Ballet JJ; Zouhair R; Bouchara JP; Favennec L
Med Mycol; 2016 May; 54(4):409-19. PubMed ID: 26486722
[TBL] [Abstract][Full Text] [Related]
5. Species-specific viability analysis of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus in mixed culture by flow cytometry.
Rüger M; Ackermann M; Reichl U
BMC Microbiol; 2014 Mar; 14():56. PubMed ID: 24606608
[TBL] [Abstract][Full Text] [Related]
6.
Homa M; Sándor A; Tóth E; Szebenyi C; Nagy G; Vágvölgyi C; Papp T
Front Microbiol; 2019; 10():441. PubMed ID: 30894846
[TBL] [Abstract][Full Text] [Related]
7.
Mello TP; Barcellos IC; Lackner M; Branquinha MH; Santos ALS
J Fungi (Basel); 2023 Apr; 9(5):. PubMed ID: 37233213
[TBL] [Abstract][Full Text] [Related]
8.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a mycelial catalase from Scedosporium boydii, a useful tool for specific antibody detection in patients with cystic fibrosis.
Mina S; Marot-Leblond A; Cimon B; Fleury MJ; Larcher G; Bouchara JP; Robert R
Clin Vaccine Immunol; 2015 Jan; 22(1):37-45. PubMed ID: 25355796
[TBL] [Abstract][Full Text] [Related]
10. Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients.
Bernhardt A; Sedlacek L; Wagner S; Schwarz C; Würstl B; Tintelnot K
J Cyst Fibros; 2013 Dec; 12(6):592-8. PubMed ID: 23764085
[TBL] [Abstract][Full Text] [Related]
11. Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis.
Zouhair R; Rougeron A; Razafimandimby B; Kobi A; Bouchara JP; Giraud S
Med Mycol; 2013 Aug; 51(6):603-13. PubMed ID: 23461512
[TBL] [Abstract][Full Text] [Related]
12. Human-impacted areas of France are environmental reservoirs of the Pseudallescheria boydii/Scedosporium apiospermum species complex.
Rougeron A; Schuliar G; Leto J; Sitterlé E; Landry D; Bougnoux ME; Kobi A; Bouchara JP; Giraud S
Environ Microbiol; 2015 Apr; 17(4):1039-48. PubMed ID: 24684308
[TBL] [Abstract][Full Text] [Related]
13. Scedosporium apiospermum complex in cystic fibrosis; should we treat?
Noni M; Katelari A; Kapi A; Stathi A; Dimopoulos G; Doudounakis SE
Mycoses; 2017 Sep; 60(9):594-599. PubMed ID: 28504471
[TBL] [Abstract][Full Text] [Related]
14. The secreted polyketide boydone A is responsible for the anti-Staphylococcus aureus activity of Scedosporium boydii.
Staerck C; Landreau A; Herbette G; Roullier C; Bertrand S; Siegler B; Larcher G; Bouchara JP; Fleury MJJ
FEMS Microbiol Lett; 2017 Dec; 364(22):. PubMed ID: 29069388
[TBL] [Abstract][Full Text] [Related]
15. Scedosporium boydii CatA1 and SODC recombinant proteins, new tools for serodiagnosis of Scedosporium infection of patients with cystic fibrosis.
Mina S; Staerck C; Marot A; Godon C; Calenda A; Bouchara JP; Fleury MJJ
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):282-287. PubMed ID: 28974395
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal and Fungicidal Activity of
Gruber M; Moser I; Nagl M; Lackner M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223376
[TBL] [Abstract][Full Text] [Related]
17. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.
Filkins LM; Graber JA; Olson DG; Dolben EL; Lynd LR; Bhuju S; O'Toole GA
J Bacteriol; 2015 Jul; 197(14):2252-64. PubMed ID: 25917910
[TBL] [Abstract][Full Text] [Related]
18. Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.
Schwab U; Abdullah LH; Perlmutt OS; Albert D; Davis CW; Arnold RR; Yankaskas JR; Gilligan P; Neubauer H; Randell SH; Boucher RC
Infect Immun; 2014 Nov; 82(11):4729-45. PubMed ID: 25156735
[TBL] [Abstract][Full Text] [Related]
19. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?
Blyth CC; Middleton PG; Harun A; Sorrell TC; Meyer W; Chen SC
Med Mycol; 2010 Nov; 48 Suppl 1():S37-44. PubMed ID: 21067328
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of the Hydroxamate Siderophore
Le Govic Y; Havlíček V; Capilla J; Luptáková D; Dumas D; Papon N; Le Gal S; Bouchara JP; Vandeputte P
Front Cell Infect Microbiol; 2020; 10():587909. PubMed ID: 33194829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
